150 related articles for article (PubMed ID: 15781660)
1. Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype.
Swinnen JV; Beckers A; Brusselmans K; Organe S; Segers J; Timmermans L; Vanderhoydonc F; Deboel L; Derua R; Waelkens E; De Schrijver E; Van de Sande T; Noël A; Foufelle F; Verhoeven G
Cancer Res; 2005 Mar; 65(6):2441-8. PubMed ID: 15781660
[TBL] [Abstract][Full Text] [Related]
2. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside.
Beckers A; Organe S; Timmermans L; Vanderhoydonc F; Deboel L; Derua R; Waelkens E; Brusselmans K; Verhoeven G; Swinnen JV
Mol Cancer Ther; 2006 Sep; 5(9):2211-7. PubMed ID: 16985054
[TBL] [Abstract][Full Text] [Related]
4. 5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2',3'-dideoxyinosine.
Gong YF; Srinivas RV; Fridland A
Mol Pharmacol; 1993 Jul; 44(1):30-6. PubMed ID: 8341276
[TBL] [Abstract][Full Text] [Related]
5. A HPLC method for simultaneous determination of 5-aminoimidazole-4-carboxamide riboside and its active metabolite 5-aminoimidazole-4-carboxamide ribotide in tumor-bearing nude mice plasma and its application to pharmacokinetics study.
Cheng X; Guo L; Li Z; Li L; Zhou T; Lu W
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb; 915-916():64-70. PubMed ID: 23340307
[TBL] [Abstract][Full Text] [Related]
6. Effect of 5-amino-4-imidazolecarboxamide riboside (AICA-riboside) on the purine nucleotide synthesis and growth of rat kidney cells in culture: study with [15N]aspartate.
Nissim I; Yudkoff M; Nissim I; States B
J Cell Physiol; 1989 Mar; 138(3):536-40. PubMed ID: 2925797
[TBL] [Abstract][Full Text] [Related]
7. AICA-riboside (acadesine), an activator of AMP-activated protein kinase with potential for application in hematologic malignancies.
Van Den Neste E; Van den Berghe G; Bontemps F
Expert Opin Investig Drugs; 2010 Apr; 19(4):571-8. PubMed ID: 20367195
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial AICA-riboside administration induces NO-dependent vasodilation in vivo in human skeletal muscle.
Bosselaar M; Boon H; van Loon LJ; van den Broek PH; Smits P; Tack CJ
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E759-66. PubMed ID: 19602584
[TBL] [Abstract][Full Text] [Related]
9. 5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells.
Garcia-Gil M; Pesi R; Perna S; Allegrini S; Giannecchini M; Camici M; Tozzi MG
Neuroscience; 2003; 117(4):811-20. PubMed ID: 12654334
[TBL] [Abstract][Full Text] [Related]
10. AICA riboside both activates AMP-activated protein kinase and competes with adenosine for the nucleoside transporter in the CA1 region of the rat hippocampus.
Gadalla AE; Pearson T; Currie AJ; Dale N; Hawley SA; Sheehan M; Hirst W; Michel AD; Randall A; Hardie DG; Frenguelli BG
J Neurochem; 2004 Mar; 88(5):1272-82. PubMed ID: 15009683
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate and 5-aminoimidazole-4-carboxamide riboside exert synergistic anticancer action against human breast cancer and hepatocellular carcinoma.
Cheng XL; Zhou TY; Li B; Li MY; Li L; Li ZQ; Lu W
Acta Pharmacol Sin; 2013 Jul; 34(7):951-9. PubMed ID: 23603981
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer.
Brunet J; Vazquez-Martin A; Colomer R; Graña-Suarez B; Martin-Castillo B; Menendez JA
Mol Carcinog; 2008 Feb; 47(2):157-63. PubMed ID: 17620310
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.
Pan Q; Bao LW; Kleer CG; Sabel MS; Griffith KA; Teknos TN; Merajver SD
Cancer Res; 2005 Sep; 65(18):8366-71. PubMed ID: 16166314
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
Zhuge J
Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
[TBL] [Abstract][Full Text] [Related]
15. 5 '-Amino-4-imidazolecarboxamide riboside induces apoptosis in human neuroblastoma cells via the mitochondrial pathway.
Garcia-Gil M; Bertini F; Pesi R; Voccoli V; Tozzi MG; Camici M
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1265-70. PubMed ID: 17065104
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo.
Xia Q; Sung J; Chowdhury W; Chen CL; Höti N; Shabbeer S; Carducci M; Rodriguez R
Cancer Res; 2006 Jul; 66(14):7237-44. PubMed ID: 16849572
[TBL] [Abstract][Full Text] [Related]
17. AMPK or ZMPK?
Shakulov RS
Med Hypotheses; 2006; 67(3):670. PubMed ID: 16762515
[No Abstract] [Full Text] [Related]
18. Inhibition of mast cell mediator release by 5-amino-4-imidazolecarboxamide riboside.
Marquardt DL; Gruber HE
Biochem Pharmacol; 1986 Dec; 35(24):4415-21. PubMed ID: 2947580
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes.
Vincent MF; Marangos PJ; Gruber HE; Van den Berghe G
Diabetes; 1991 Oct; 40(10):1259-66. PubMed ID: 1657665
[TBL] [Abstract][Full Text] [Related]
20. ErbB-4 may control behavior of prostate cancer cells and serve as a target for molecular therapy.
Ben-Yosef R; Starr A; Karaush V; Loew V; Lev-Ari S; Barnea I; Lidawi G; Shtabsky A; Greif Y; Yarden Y; Vexler A
Prostate; 2007 Jun; 67(8):871-80. PubMed ID: 17440944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
